Sphingosine-1-phosphate (S1P) represents one of the key latest additions to the list of vasoactive substances that modulate vascular tone. Proteinase activated receptor-2 (PAR-2) has been shown to be involved in cardiovascular function. In the present study we investigated the involvement of PAR-2 in S1P-induced effect on vascular tone. This study has been performed by using isolated mouse aortas. Both S1P and PAR-2 agonists induce endothelium-dependent vasorelaxation. L-NAME and wortmannin abrogate S1P-induced vasorelaxatioin, while significantly inhibit PAR-2 mediated effect. Either ENMD1068, a PAR-2 antagonist or gabexate, a serine protease inhibitor, significantly inhibit S1P-induced vasorelaxation. Aortic tissues harvested from mice overexpressing PAR-2 display a significant increased vascular response to S1P as opposite to PAR-2 null mice. Immunoprecipitation and immunofluorescence studies demonstrate that S1P1 interacts with PAR-2 and co-localizes with PAR-2 on the vascular endothelial surface. Furthermore S1P administration to vascular tissues triggers PAR-2 mobilization from the plasma membrane to the perinuclear area; S1P-induced translocation of PAR-2 is abrogated when aortic rings were pretreated with ENMD1068 or when caveolae dysfunction occurs. Similarly, experiments performed in cultured endothelial cells (HUVEC) show a colocalization of S1P1 and PAR2, as well as S1P ability to induce PAR-2 trafficking. Our results suggest that S1P induces endothelium dependent vasorelaxation mainly through S1P1 and involves PAR-2 transactivation

Involvement of proteinase activated receptor-2 in vascular response to sphingosine-1-phosphate / Roviezzo, Fiorentina; Antonella De, Angelis; Luana De, Gruttola; Bertolino, Antonio; Nikol, Sullo; Vincenzo, Brancaleone; Bucci, Mariarosaria; Raffaele De, Palma; Konrad, Urbanek; Bruno, D'Agostino; Ianaro, Angela; Sorrentino, Raffaella; Cirino, Giuseppe; Urbanek, Konrad Arkadiusz. - In: CLINICAL SCIENCE. - ISSN 0143-5221. - 126:8(2014), pp. 545-556. [10.1042/CS20130272]

Involvement of proteinase activated receptor-2 in vascular response to sphingosine-1-phosphate

ROVIEZZO, FIORENTINA;BERTOLINO, ANTONIO;BUCCI, MARIAROSARIA;IANARO, ANGELA;SORRENTINO, RAFFAELLA;CIRINO, GIUSEPPE;URBANEK, Konrad Arkadiusz
2014

Abstract

Sphingosine-1-phosphate (S1P) represents one of the key latest additions to the list of vasoactive substances that modulate vascular tone. Proteinase activated receptor-2 (PAR-2) has been shown to be involved in cardiovascular function. In the present study we investigated the involvement of PAR-2 in S1P-induced effect on vascular tone. This study has been performed by using isolated mouse aortas. Both S1P and PAR-2 agonists induce endothelium-dependent vasorelaxation. L-NAME and wortmannin abrogate S1P-induced vasorelaxatioin, while significantly inhibit PAR-2 mediated effect. Either ENMD1068, a PAR-2 antagonist or gabexate, a serine protease inhibitor, significantly inhibit S1P-induced vasorelaxation. Aortic tissues harvested from mice overexpressing PAR-2 display a significant increased vascular response to S1P as opposite to PAR-2 null mice. Immunoprecipitation and immunofluorescence studies demonstrate that S1P1 interacts with PAR-2 and co-localizes with PAR-2 on the vascular endothelial surface. Furthermore S1P administration to vascular tissues triggers PAR-2 mobilization from the plasma membrane to the perinuclear area; S1P-induced translocation of PAR-2 is abrogated when aortic rings were pretreated with ENMD1068 or when caveolae dysfunction occurs. Similarly, experiments performed in cultured endothelial cells (HUVEC) show a colocalization of S1P1 and PAR2, as well as S1P ability to induce PAR-2 trafficking. Our results suggest that S1P induces endothelium dependent vasorelaxation mainly through S1P1 and involves PAR-2 transactivation
2014
Involvement of proteinase activated receptor-2 in vascular response to sphingosine-1-phosphate / Roviezzo, Fiorentina; Antonella De, Angelis; Luana De, Gruttola; Bertolino, Antonio; Nikol, Sullo; Vincenzo, Brancaleone; Bucci, Mariarosaria; Raffaele De, Palma; Konrad, Urbanek; Bruno, D'Agostino; Ianaro, Angela; Sorrentino, Raffaella; Cirino, Giuseppe; Urbanek, Konrad Arkadiusz. - In: CLINICAL SCIENCE. - ISSN 0143-5221. - 126:8(2014), pp. 545-556. [10.1042/CS20130272]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/563863
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact